Articles about 'Sabine Bahn'

Researchers have developed a new way of improving diagnosis of bipolar disorder that uses a simple blood test to identify biomarkers associated with the condition.

Psychiatrist, Professor of Neurotechnology and 'Enterprising Mind', Sabine Bahn has founded two companies both with the aim of helping people with mental health disorders get a faster diagnosis and better access to the right treatment.

Researchers have developed a method that could drastically accelerate the search for new drugs to treat mental health disorders such as schizophrenia.

A new blood-test resulting from research at Cambridge University could aid in the early diagnosis of recent-onset schizophrenia - complementing the traditional patient interview-based diagnosis.

Recent funding of over $5 million to Dr Sabine Bahn by the Stanley Medical Research Institute (SMRI) raises diagnostic and therapeutic hopes for a group of psychiatric diseases that affects 2% of the population.